AwardTape · Defense awards · Neurohope Therapeutics, Inc
Neurohope Therapeutics, Inc: $1.5M in DoD and DHS awards
Neurohope Therapeutics, Inc holds 2 DoD and DHS prime awards with $1.5M obligated Jan 31, 2025 to May 26, 2026. Largest category: Health R&D at $1.5M; largest buyer: Defense Health Agency at $1.5M.
| Obligated FY2024+ | $1.5M |
|---|---|
| Awards | 2 |
| FY2024 | $0 |
| FY2025 | $249K |
| FY2026 to date | $1.3M |
| Lifetime obligated on these awards | $1.5M |
| Parent company (as reported) | Neurohope Therapeutics, Inc |
| First and latest action | Jan 31, 2025 · May 26, 2026 |
| # | Category | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Health R&D | $1.5M | 2 awards | 100% |
| # | Agency | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Defense Health Agency | $1.5M | 2 awards | 100% |
| Award | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|
| HT942726CE012 definitive contract | $1.3M | Dexamethasone nanotherapeutics for traumatic brain injury | Defense Health Agency | Health R&D | May 26, 2026 DoD 90d |
| HT942525P0023 purchase order | $249K | Dha sbir phase i for project titled, "dexamethasone nanotherapeutics for traumatic brain injury" | Defense Health Agency | Health R&D | Apr 1, 2025 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 9, 2026.
Terminal: filters, alerts and CSV export for this company's awards.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial